The store will not work correctly when cookies are disabled.
4-(2,3-Dichlorophenyl)-6-methyl-1H-benzo[d]imidazol-2-amine
ID: ALA4568781
PubChem CID: 155560275
Max Phase: Preclinical
Molecular Formula: C14H11Cl2N3
Molecular Weight: 292.17
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc(-c2cccc(Cl)c2Cl)c2nc(N)[nH]c2c1
Standard InChI: InChI=1S/C14H11Cl2N3/c1-7-5-9(8-3-2-4-10(15)12(8)16)13-11(6-7)18-14(17)19-13/h2-6H,1H3,(H3,17,18,19)
Standard InChI Key: RPTCZMDHFOOKHF-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
20.1323 -21.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8420 -20.7948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8392 -19.9721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1306 -19.5669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4243 -20.7953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4210 -19.9742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6391 -19.7237 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.1591 -20.3899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6445 -21.0521 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.3385 -20.3844 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.1340 -22.0193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4246 -22.4271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4240 -23.2435 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1322 -23.6531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8423 -23.2403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8394 -22.4252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5461 -22.0148 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
21.5514 -23.6466 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
21.5453 -19.5609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 6 2 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
8 10 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
1 11 1 0
16 17 1 0
15 18 1 0
3 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 292.17 | Molecular Weight (Monoisotopic): 291.0330 | AlogP: 4.43 | #Rotatable Bonds: 1 |
Polar Surface Area: 54.70 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.63 | CX Basic pKa: 7.95 | CX LogP: 4.48 | CX LogD: 3.88 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.70 | Np Likeness Score: -0.69 |
References
1. Farand J, Kropf JE, Blomgren P, Xu J, Schmitt AC, Newby ZE, Wang T, Murakami E, Barauskas O, Sudhamsu J, Feng JY, Niedziela-Majka A, Schultz BE, Schwartz K, Viatchenko-Karpinski S, Kornyeyev D, Kashishian A, Fan P, Chen X, Lansdon EB, Ports MO, Currie KS, Watkins WJ, Notte GT.. (2020) Discovery of Potent and Selective MTH1 Inhibitors for Oncology: Enabling Rapid Target (In)Validation., 11 (3): [PMID:32184970] [10.1021/acsmedchemlett.9b00420] |